Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Mankind Pharma Limited

Capitalization 88TCr 954.61Cr 834.43Cr 753.86Cr 721.15Cr 1.31TCr 1.36TCr 9.01TCr 3.57TCr 42TCr 3.58TCr 3.51TCr 1,52400Cr P/E ratio 2026 *
46.8x
P/E ratio 2027 * 36.1x
Enterprise value 94TCr 1.01TCr 885.48Cr 799.98Cr 765.27Cr 1.39TCr 1.45TCr 9.56TCr 3.79TCr 45TCr 3.8TCr 3.72TCr 1,61700Cr EV / Sales 2026 *
6.52x
EV / Sales 2027 * 5.7x
Free-Float
22.83%
Yield 2026 *
0.19%
Yield 2027 * 0.29%
1 day-3.13%
1 week-2.20%
Current month-4.84%
1 month+3.80%
3 months-1.83%
6 months-17.08%
Current year-2.62%
1 week 2,108.3
Extreme 2108.3
2,256.8
1 month 2,012.3
Extreme 2012.3
2,284.9
Current year 2,012.3
Extreme 2012.3
2,320.9
1 year 2,012.3
Extreme 2012.3
2,716.5
3 years 1,242
Extreme 1242
3,054.8
5 years 1,242
Extreme 1242
3,054.8
10 years 1,242
Extreme 1242
3,054.8
Manager TitleAgeSince
Chief Executive Officer 50 21/09/2007
Director of Finance/CFO 57 03/03/2016
Compliance Officer 48 09/01/2025
Director TitleAgeSince
Chairman 70 03/07/1991
Director/Board Member 60 22/12/1992
Director/Board Member 50 21/09/2007
Change 5d. change 1-year change 3-years change Capi.($)
-3.13%-2.20%-2.83% - 954.61Cr
+0.80%-0.53%+21.09%+201.18% 88TCr
-0.21%+0.47%+48.34%+56.91% 58TCr
-2.52%-4.53%+3.74%+42.79% 39TCr
+0.79%-6.01%+4.87%+20.81% 32TCr
+0.11%-0.83%+19.89%+34.57% 30TCr
+0.43%-1.54%+25.96%+62.12% 29TCr
-0.26%-0.16%+22.25%+8.08% 29TCr
-0.43%-0.90%+16.74%+58.82% 20TCr
+0.42%+0.74%+30.11%+81.76% 18TCr
Average -0.40%-1.55%+19.02%+63.00% 34.36TCr
Weighted average by Cap. -0.03%-1.37%+22.78%+84.81%

Financials

2026 *2027 *
Net sales 14TCr 155.32Cr 135.76Cr 122.65Cr 117.33Cr 213.41Cr 221.84Cr 1.47TCr 580.66Cr 6.86TCr 582.82Cr 570.51Cr 25TCr 16TCr 172.8Cr 151.04Cr 136.46Cr 130.54Cr 237.43Cr 246.81Cr 1.63TCr 646.03Cr 7.64TCr 648.43Cr 634.73Cr 28TCr
Net income 1.85TCr 20Cr 17Cr 16Cr 15Cr 28Cr 29Cr 188.85Cr 75Cr 884.59Cr 75Cr 74Cr 3.2TCr 2.44TCr 26Cr 23Cr 21Cr 20Cr 36Cr 38Cr 248.39Cr 98Cr 1.16TCr 99Cr 97Cr 4.2TCr
Net Debt 5.4TCr 58Cr 51Cr 46Cr 44Cr 80Cr 83Cr 550.97Cr 218.35Cr 2.58TCr 219.16Cr 214.53Cr 9.32TCr 2.87TCr 31Cr 27Cr 24Cr 23Cr 43Cr 44Cr 292.37Cr 115.87Cr 1.37TCr 116.3Cr 113.84Cr 4.95TCr
Logo Mankind Pharma Limited
Mankind Pharma Limited is an India-based pharmaceutical company. It is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It offers healthcare solutions for a range of healthcare needs with a portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/ central nervous system, vitamins, minerals and nutrients and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. Its branded product portfolio spans women’s health, fertility and critical care, with several brands in their respective therapy areas. Its subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Jaspack Industries Private Limited, and others.
Employees
19,620
Date Price Change Volume
13/26/13 2,138.90 -3.13% 8,01,859
12/26/12 2,207.90 -1.60% 3,10,028
11/26/11 2,243.80 +0.27% 4,15,703
10/26/10 2,237.70 +3.44% 10,43,920
09/26/09 2,163.30 -1.08% 8,26,127
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
2,138.90INR
Average target price
2,506.89INR
Spread / Average Target
+17.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MANKIND Stock
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW